Telehealth LedgerCompare care clearly
503A state-licensed compounding pharmacy

AbsoluteRx

Absolute Pharmacy, LLC dba Absolute RX, 16011 N. Nebraska Ave., Suite 103, Lutz, Florida. Public-record profile of a pharmacy that fills telehealth prescriptions; records checked 10 September 2026.

503Aregistration type
5public regulatory records
Nopublished BUD or testing policy
1providers naming it

Which telehealth providers use AbsoluteRx

One telehealth provider in the Telehealth Ledger directory names AbsoluteRx as a fulfillment pharmacy on its own public pages: MadeMed. Each name below links to that provider's profile, where the pharmacy statement sits beside its dated source.

MadeMed's pharmacy disclosure, as recorded in its dossier: Quoted from MadeMed's terms: "prescription fulfillment services offered by our partner pharmacies, including AbsoluteRx (the "Pharmacy")."

Naming a pharmacy does not mean every prescription goes there. Most telehealth services list several partners and route each order by medication, state licensure, and stock, so the pharmacy on your label can differ from the marketing page. The vial label is the authoritative record of who compounded and dispensed it.

503A vs 503B compounding pharmacy: what it means for your prescription

AbsoluteRx is recorded here as a 503A compounding pharmacy. Its homepage and about page say 503A patient-specific only. FDA's compounding actions index records the firm as de-registered as an outsourcing facility after a 2014 registration under section 503B, and it does not appear on the current registered outsourcing facility list (checked 2026-09-10).

A 503A pharmacy compounds a patient-specific prescription and is licensed and inspected primarily by its state board of pharmacy; it does not register with FDA as an outsourcing facility and is not required to follow federal current good manufacturing practice (CGMP). Compounded semaglutide or tirzepatide from a 503A pharmacy is not an FDA-approved product, and the beyond-use date on the label comes from the pharmacy's own stability practice under USP standards rather than from an approved drug application.

FDA inspection history and public regulatory records

5 public regulatory records for AbsoluteRx were found in the databases checked on 10 September 2026. Each is summarized neutrally below, in date order, with a link to the primary document. A record is a fact about a filing, not a judgment about current practice: a Form 483 lists an inspector's observations, a warning letter states FDA's position after review, and a close-out letter records that FDA considers the letter's issues addressed.

Databases checked: FDA registered outsourcing facilities list (updated 2026-09-08) (no record found); FDA compounding inspections, recalls, and other actions (record found).

If a new letter, action, or recall appears, it is added with its date and primary link and earlier summaries are not rewritten.

  1. 19 November 2014 · FDA: Form FDA 483. FDA issued an inspectional observation list after an October to November 2014 inspection; the posted document is a scanned image. Primary document
  2. 27 April 2015 · FDA: Warning letter FLA-15-21. The letter, listed on FDA's compounding actions index, noted the firm's 2014 registration as an outsourcing facility and described deficiencies observed in sterile drug production practices. Primary document
  3. 11 April 2016 · FDA: Form FDA 483. FDA issued a second inspectional observation list after a March to April 2016 inspection. Primary document
  4. 15 February 2017 · FDA: Referral letter to the Florida Board of Pharmacy. FDA referred sterile-practice observations from the 2016 inspection to the Florida board, noted the firm appeared to compound on patient-specific prescriptions, and stated it did not intend further action. Primary document
  5. 14 July 2021 · FDA: Warning letter close-out and FMD-145 letter. FDA's compounding actions index lists a warning letter close-out and an FMD-145 letter on this date and records the firm as de-registered as an outsourcing facility. Primary document

State pharmacy license and accreditation

Florida Department of Health (MQA) lists Absolute Pharmacy, LLC dba Absolute RX under license PH28122 with the status "Clear; community pharmacy, issued 2014-05-07, expires 2027-02-28, no discipline on file, no public complaint" when checked on 10 September 2026. A resident license in Florida covers dispensing from that address; shipping to patients in other states requires a separate non-resident pharmacy license in each of those states, which is why provider availability lists change by state.

No NABP accreditation (PCAB, Digital Pharmacy, or similar) was found listed for this pharmacy on the dates checked. Accreditation is voluntary and its absence is not a finding.

Beyond-use date (BUD) and testing policy

AbsoluteRx does not publish a beyond-use date policy, stability study, or testing statement on the public pages checked. Many compounding pharmacies share this only with the prescribing provider or on request, so "not found" describes the public website, not the pharmacy's records.

A beyond-use date (BUD) is the date after which a compounded preparation must not be used; the pharmacy assigns it under USP <797> sterile compounding standards and prints it on the dispensing label. It is not the same as a manufacturer's expiration date on a brand pen. Follow the storage and BUD printed on your pharmacy label; if a vial arrives without one, ask the dispensing pharmacy before use.

How compounded GLP-1 medication is shipped from this pharmacy

AbsoluteRx describes its shipping this way: "Cold-chain Delivery: Temperature-controlled options to protect every formula"

Provider shipping claims: MadeMed says Quoted from MadeMed's how-it-works page: "Discreet Delivery, Free Shipping*".

Compounded semaglutide and tirzepatide ship refrigerated: an insulated box with cold packs, usually by an overnight or two-day carrier service on weekdays so a package is never in transit over a weekend. On arrival, put the vial in the refrigerator, check the label for the BUD and storage line, and contact the pharmacy if the cold pack is fully thawed or the vial is warm.

Verification notes

  • FDA's 2017 referral letter listed a sterile compounding permit PH28269 alongside community permit PH28122. PH28269 did not appear on the Florida record checked and its current status was not found.
  • The text of the 2015 warning letter was located only on a third-party mirror; FDA's compounding actions index lists the letter, and that index is the URL cited here.
  • The pharmacy's 2021 press release says it is LegitScript certified and licensed for prescription fulfillment in 49 states; its homepage says most prescriptions ship the same day with 2 to 7 day options. No NABP or PCAB accreditation was found.
  • A third-party company profile quotes a stability-assay and batch-sterility-testing statement attributed to the pharmacy. It was not found on absoluterx.com and is not recorded here.

Questions about AbsoluteRx

Is AbsoluteRx a 503A or 503B pharmacy?
AbsoluteRx is recorded as a 503A state-licensed compounding pharmacy. Its homepage and about page say 503A patient-specific only. FDA's compounding actions index records the firm as de-registered as an outsourcing facility after a 2014 registration under section 503B, and it does not appear on the current registered outsourcing facility list (checked 2026-09-10).
Has FDA issued a warning letter to AbsoluteRx?
5 public regulatory records are listed on this page with primary links: Form FDA 483 (19 November 2014); Warning letter FLA-15-21 (27 April 2015); Form FDA 483 (11 April 2016); Referral letter to the Florida Board of Pharmacy (15 February 2017); Warning letter close-out and FMD-145 letter (14 July 2021).
Which telehealth providers use AbsoluteRx?
MadeMed name AbsoluteRx on their public pages. Assignment can vary by medication, state, and stock; the dispensing label shows the pharmacy that filled your order.

Sources

Every statement above links to the public record it came from, checked on the date shown. “Not found” describes that search, not the pharmacy. For the full process from consult to refrigerator, read how the medication reaches you.